In addition, several lines of evidence suggest that HIFs promote the expansion of CD133-positive glioma cells [19] or expression of CD133 in lung cancer cells [20]; however, how the expression of the CSC marker protein is regulated by HIF-1α and HIF-2α remains largely unknown. This evidence concerns the gene HIF1A and central nervous system cancer.